Frontiers in Allergy | Asthma section | New and Recent Articles https://www.frontiersin.org/journals/allergy/sections/asthma RSS Feed for Asthma section in the Frontiers in Allergy journal | New and Recent Articles en-us Frontiers Feed Generator,version:1 2026-05-13T21:23:23.368+00:00 60 https://www.frontiersin.org/articles/10.3389/falgy.2026.1666241 https://www.frontiersin.org/articles/10.3389/falgy.2026.1666241 <![CDATA[Actual use of PROMs in asthma and rhinitis recommended by guidelines in clinical settings: PROMUSE respiratory study]]> 2026-04-24T00:00:00Z Original Research Ivan Cherrez-OjedaJean BousquetTorsten ZuberbierJuan C. CalderonPavel KolkhirAnastasiia AllenovaAndrey AllenovSergey TkachenkoFlorin MihaltanRuxandra UlmeanuMona Al-AhmadMònica Rodriguez-GonzálezGuillermo Wakida-KusunokiGerman D. RamonMaia RukhadzeDésirée E. Larenas-LinnemannMitja KošnikJuan Carlos IvancevichLuis Felipe EnsinaNelson A. Rosario FilhoVioleta KvedarieneHerberto Jose Chong-NetoIvan TinocoAnna BedbrookGabriela Rodas-ValeroMarco Faytong-HaroMarcus MaurerOliver PfaarKarla Robles-Velasco  0.05 across all groups).ConclusionsThe use of PROMs is suboptimal, primarily due to time limitations. It is imperative that methods be swiftly implemented to include these techniques into the therapeutic environment to attain enhanced outcomes.]]> https://www.frontiersin.org/articles/10.3389/falgy.2026.1740307 https://www.frontiersin.org/articles/10.3389/falgy.2026.1740307 <![CDATA[The testosterone paradox in asthma]]> 2026-04-23T00:00:00Z Mini Review Ynuk Bossé https://www.frontiersin.org/articles/10.3389/falgy.2026.1772380 https://www.frontiersin.org/articles/10.3389/falgy.2026.1772380 <![CDATA[Asthma and corticosteroids “odi et amo”: how to deal with it?]]> 2026-04-13T00:00:00Z Mini Review Luca BorsariLaura CarbonieriLuca M. VerdiniValentina RuggieriBianca Beghe’ https://www.frontiersin.org/articles/10.3389/falgy.2026.1840104 https://www.frontiersin.org/articles/10.3389/falgy.2026.1840104 <![CDATA[Editorial: Biologics for airway diseases: from bench to bedside]]> 2026-04-10T00:00:00Z Editorial Andreas M. MatthaiouNikoleta BizymiDina ViscaLena UllerNikolaos G. PapadopoulosAlexander G. Mathioudakis https://www.frontiersin.org/articles/10.3389/falgy.2026.1667661 https://www.frontiersin.org/articles/10.3389/falgy.2026.1667661 <![CDATA[One-session asthma curriculum for all K–8th grade students: impact on knowledge, attitudes, and self-efficacy]]> 2026-04-09T00:00:00Z Original Research Caroline LuffAlexandra KnitterBolanle OgbaraLaToya GregoryMonica KowalczykAnna Volerman https://www.frontiersin.org/articles/10.3389/falgy.2026.1789783 https://www.frontiersin.org/articles/10.3389/falgy.2026.1789783 <![CDATA[Impact of sputum neutrophilia on the efficacy of biologics in severe asthma]]> 2026-04-08T00:00:00Z Original Research Patrizia PignattiMartina ZappaFrancesco ArdesiMarco VanettiRosella CentisAntonio SpanevelloDina Visca https://www.frontiersin.org/articles/10.3389/falgy.2026.1766647 https://www.frontiersin.org/articles/10.3389/falgy.2026.1766647 <![CDATA[Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis]]> 2026-03-06T00:00:00Z Original Research Enrico HefflerDiana JarretaChang-Qing ZhuAnna VichiendilokkulPeter HowarthAnju PetersSantiago QuirceDavid J. Jackson https://www.frontiersin.org/articles/10.3389/falgy.2026.1746439 https://www.frontiersin.org/articles/10.3389/falgy.2026.1746439 <![CDATA[Long-term Qipian® administration confers resistance to airway inflammation in OVA-induced asthmatic mice]]> 2026-02-26T00:00:00Z Original Research Huiying WangRu-Yi ChenJin-Jin ShiGuan-Jun YangJiong Chen https://www.frontiersin.org/articles/10.3389/falgy.2026.1738118 https://www.frontiersin.org/articles/10.3389/falgy.2026.1738118 <![CDATA[Understanding disease burden, challenges in current treatment strategies and call for action for management of severe asthma in Asia: a position statement from Asian respiratory experts]]> 2026-02-26T00:00:00Z Review Mariko Siyue KohKen Ka Pang ChanKoichi FukunagaSang-Heon KimLe Thi Tuyet LanAzza OmarThitiwat SriprasartDeepak TalwarMin ZhangShih-Lung Cheng https://www.frontiersin.org/articles/10.3389/falgy.2026.1797785 https://www.frontiersin.org/articles/10.3389/falgy.2026.1797785 <![CDATA[Editorial: The role of epithelial-derived cytokines in airway disease]]> 2026-02-24T00:00:00Z Editorial Hector OrtegaKian Fan Chung https://www.frontiersin.org/articles/10.3389/falgy.2026.1758940 https://www.frontiersin.org/articles/10.3389/falgy.2026.1758940 <![CDATA[Silent invaders: the role of MPs on epithelium inflammation and damage in airway diseases]]> 2026-02-16T00:00:00Z Mini Review Benedetta BondiStefania NicolaFederico Di MarcoSara ChiapporiLuisa BrussinoLaura De FerrariAnna Maria RiccioFulvio BraidoDiego Bagnasco https://www.frontiersin.org/articles/10.3389/falgy.2026.1741154 https://www.frontiersin.org/articles/10.3389/falgy.2026.1741154 <![CDATA[Association between impulse oscillometry Z-scores and asthma control and exacerbation risk in a tertiary severe asthma clinic]]> 2026-02-12T00:00:00Z Original Research Li Ping ChungDylan BeinartEmily S. Y. GohGregory G. King 1.64) for R5 were associated with a higher risk of exacerbations (OR 2.70, 95% CI 1.27–5.17, P = 0.009). The risk of exacerbation increased with the severity of airway obstruction. Similar trends were observed for AX and X5; however, these associations did not reach statistical significance.DiscussionThe presence and severity of airway obstruction, as defined by R5 Z-scores, predict poorer asthma control and an increased risk of exacerbations. Similar associations with asthma control were also observed for X5 and AX Z-scores. Clinicians should use Z-scores over other cutoffs to aid interpretation.]]> https://www.frontiersin.org/articles/10.3389/falgy.2026.1748679 https://www.frontiersin.org/articles/10.3389/falgy.2026.1748679 <![CDATA[EGFR inhibitors suppress house dust mite allergen Der pII induced inflammation in monocytes and macrophages]]> 2026-02-06T00:00:00Z Original Research Ya-Hui ChiangI-Lun HsinPing-Ju ChenHui-Yi ChangJiunn-Liang KoKo-Huang LueYu-Fan Liu https://www.frontiersin.org/articles/10.3389/falgy.2026.1731295 https://www.frontiersin.org/articles/10.3389/falgy.2026.1731295 <![CDATA[Pentraxin 3 deficiency exacerbates neutrophilic inflammation and airway hyperresponsiveness in type 2-low asthma]]> 2026-02-05T00:00:00Z Original Research Sina TaefehshokrLianyu ShanMojdeh MatloubiSujata BasuA. HalaykoAbdelilah S. Gounni https://www.frontiersin.org/articles/10.3389/falgy.2025.1707834 https://www.frontiersin.org/articles/10.3389/falgy.2025.1707834 <![CDATA[A randomized, double-blind, placebo-controlled trial of soluble corn fiber supplementation for children with asthma]]> 2026-01-21T00:00:00Z Clinical Trial Matthew A. RankDaisy L. BarrosoKathryn A. ConnMelissa PecakMatthew ScanduraAllyson H. HirschHaiwei GuCorrie M. WhisnerHeather ShearerDarcy JohnsonNatalia ArgelCindy S. BauerSophia N. WilliamsBenjamin L. WrightJames WoodwardEmily K. Cope https://www.frontiersin.org/articles/10.3389/falgy.2025.1759789 https://www.frontiersin.org/articles/10.3389/falgy.2025.1759789 <![CDATA[Editorial: Exploring the interconnection: obesity's role in asthma development and management]]> 2026-01-21T00:00:00Z Editorial Akira YamasakiKatsuyuki Tomita https://www.frontiersin.org/articles/10.3389/falgy.2025.1635540 https://www.frontiersin.org/articles/10.3389/falgy.2025.1635540 <![CDATA[Case Report: Extending dosing intervals of biologics in adults severe asthma: a case series]]> 2026-01-21T00:00:00Z Case Report Tomoya HaradaMiyu NishigamiHiroyuki TanakaGenki InuiHiroki IshikawaHiroki KohnoYoshihiro FunakiTomohiro SakamotoMiki TakataRyota OkazakiMasato MoritaShin KitataniAkira Yamasaki https://www.frontiersin.org/articles/10.3389/falgy.2026.1757445 https://www.frontiersin.org/articles/10.3389/falgy.2026.1757445 <![CDATA[Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection]]> 2026-01-20T00:00:00Z Review Enrico TondinaAlessia Claudia CodazziRiccardo CastorinaRossana Di MiccoCristina DuttoLivia Leoncini BartoliGiovanni LeporeGian Luigi MarsegliaIlaria Brambilla https://www.frontiersin.org/articles/10.3389/falgy.2025.1754173 https://www.frontiersin.org/articles/10.3389/falgy.2025.1754173 <![CDATA[Endotype-driven decisions in choosing a biologic for airway diseases]]> 2026-01-12T00:00:00Z Review Carmen PanaitescuLaura HaidarMaria-Roxana BuzanRăzvan-Ionuț ZimbruValentin-Cristian IovinElena-Larisa ZimbruAlexandru LăculiceanuIoana Agache https://www.frontiersin.org/articles/10.3389/falgy.2025.1719820 https://www.frontiersin.org/articles/10.3389/falgy.2025.1719820 <![CDATA[Using biomarkers and independent predictors of therapy response to optimize treatment of uncontrolled severe asthma in the biologic era]]> 2026-01-09T00:00:00Z Review Hideki Yasui